Source:http://linkedlifedata.com/resource/pubmed/id/10212715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-6-16
|
pubmed:abstractText |
We assessed the effect of two different doses of alfentanil (5 and 10 micrograms.kg-1) on the conditions for laryngeal mask airway insertion in ASA 1 and 2 patients who received propofol for induction of anaesthesia. One hundred and fifty unpremedicated patients were randomly allocated to receive either propofol 2.5 mg.kg-1 only (Group P), alfentanil 5 micrograms.kg-1 and propofol 2.5 mg.kg-1 (Group A5), or alfentanil 10 micrograms.kg-1 and propofol 2.5 mg.kg-1 (Group A10). The addition of alfentanil to propofol resulted in a greater ease of insertion and a better quality of airway patency. Pretreatment with alfentanil also resulted in a significantly higher success rate during the first attempt at inserting the laryngeal mask airway compared with Group P (Group P 58%, Group A5 96%, Group A10 94%). Patients in Group P were apnoeic for a mean (+/- SD) time of 3.3(+/- 1.9) min, 4.71 (+/- 2.2) min in Group A5, and 7.32(+/- 4.3) min in Group A10. The use of alfentanil 10 micrograms.kg-1 with propofol, however, led to a significant decrease in mean arterial pressure and heart rate. We concluded that pretreatment with intravenous alfentanil 5 micrograms.kg-1 prior to propofol provides excellent conditions for insertion of laryngeal mask with minimal adverse haemodynamic changes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alfentanil,
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics, Opioid,
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Combined,
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Intravenous,
http://linkedlifedata.com/resource/pubmed/chemical/Propofol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0310-057X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10212715-Adult,
pubmed-meshheading:10212715-Alfentanil,
pubmed-meshheading:10212715-Analgesics, Opioid,
pubmed-meshheading:10212715-Anesthesia,
pubmed-meshheading:10212715-Anesthetics, Combined,
pubmed-meshheading:10212715-Anesthetics, Intravenous,
pubmed-meshheading:10212715-Apnea,
pubmed-meshheading:10212715-Dose-Response Relationship, Drug,
pubmed-meshheading:10212715-Female,
pubmed-meshheading:10212715-Humans,
pubmed-meshheading:10212715-Laryngeal Masks,
pubmed-meshheading:10212715-Male,
pubmed-meshheading:10212715-Middle Aged,
pubmed-meshheading:10212715-Preanesthetic Medication,
pubmed-meshheading:10212715-Propofol
|
pubmed:year |
1999
|
pubmed:articleTitle |
Alfentanil co-induction for laryngeal mask insertion.
|
pubmed:affiliation |
Department of Anaesthesia, National University Hospital, Singapore.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|